170 related articles for article (PubMed ID: 22929306)
1. The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1.
Peacocke J; Lotz Z; de Beer C; Roux P; Mall AS
Virol J; 2012 Aug; 9():177. PubMed ID: 22929306
[TBL] [Abstract][Full Text] [Related]
2. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
Habte HH; de Beer C; Lotz ZE; Roux P; Mall AS
Virol J; 2010 Oct; 7():269. PubMed ID: 20946627
[TBL] [Abstract][Full Text] [Related]
4. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
McQuaid IK; Dorfman JR; Mall AS
Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
Wickström C; Christersson C; Davies JR; Carlstedt I
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
[TBL] [Abstract][Full Text] [Related]
6. Purified human breast milk MUC1 and MUC4 inhibit human immunodeficiency virus.
Mthembu Y; Lotz Z; Tyler M; de Beer C; Rodrigues J; Schoeman L; Mall AS
Neonatology; 2014; 105(3):211-7. PubMed ID: 24503884
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay.
Habte HH; de Beer C; Lotz ZE; Tyler MG; Schoeman L; Kahn D; Mall AS
Virol J; 2008 May; 5():59. PubMed ID: 18489743
[TBL] [Abstract][Full Text] [Related]
8. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7.
Rousseau K; Wickstrom C; Whitehouse DB; Carlstedt I; Swallow DM
Hybrid Hybridomics; 2003 Oct; 22(5):293-9. PubMed ID: 14678646
[TBL] [Abstract][Full Text] [Related]
9. Degradation of MUC7 and MUC5B in human saliva.
Takehara S; Yanagishita M; Podyma-Inoue KA; Kawaguchi Y
PLoS One; 2013; 8(7):e69059. PubMed ID: 23874867
[TBL] [Abstract][Full Text] [Related]
10. Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
Mall AS; Habte H; Mthembu Y; Peacocke J; de Beer C
Virol J; 2017 Oct; 14(1):192. PubMed ID: 28985745
[TBL] [Abstract][Full Text] [Related]
11. Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product.
Thornton DJ; Khan N; Mehrotra R; Howard M; Veerman E; Packer NH; Sheehan JK
Glycobiology; 1999 Mar; 9(3):293-302. PubMed ID: 10024667
[TBL] [Abstract][Full Text] [Related]
12. Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association.
Mehrotra R; Thornton DJ; Sheehan JK
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):415-22. PubMed ID: 9716500
[TBL] [Abstract][Full Text] [Related]
13. Reorganisation of the salivary mucin network by dietary components: insights from green tea polyphenols.
Davies HS; Pudney PD; Georgiades P; Waigh TA; Hodson NW; Ridley CE; Blanch EW; Thornton DJ
PLoS One; 2014; 9(9):e108372. PubMed ID: 25264771
[TBL] [Abstract][Full Text] [Related]
14. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B.
Nielsen PA; Bennett EP; Wandall HH; Therkildsen MH; Hannibal J; Clausen H
Glycobiology; 1997 Apr; 7(3):413-9. PubMed ID: 9147051
[TBL] [Abstract][Full Text] [Related]
15. MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients.
Szkaradkiewicz-Karpińska AK; Ronij A; Goślińska-Kuźniarek O; Przybyłek I; Szkaradkiewicz A
Int J Med Sci; 2019; 16(2):241-246. PubMed ID: 30745804
[No Abstract] [Full Text] [Related]
16. Interaction of HIV-1 and human salivary mucins.
Bergey EJ; Cho MI; Blumberg BM; Hammarskjöld ML; Rekosh D; Epstein LG; Levine MJ
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):995-1002. PubMed ID: 8083829
[TBL] [Abstract][Full Text] [Related]
17. Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori.
Silva DG; Stevens RH; Macedo JM; Hirata R; Pinto AC; Alves LM; Veerman EC; Tinoco EM
Arch Oral Biol; 2009 Jan; 54(1):86-90. PubMed ID: 18817906
[TBL] [Abstract][Full Text] [Related]
18. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage.
Wickström C; Davies JR; Eriksen GV; Veerman EC; Carlstedt I
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):685-93. PubMed ID: 9729478
[TBL] [Abstract][Full Text] [Related]
19. N-terminal cleavage of the salivary MUC5B mucin. Analogy with the Van Willebrand propolypeptide?
Wickström C; Carlstedt I
J Biol Chem; 2001 Dec; 276(50):47116-21. PubMed ID: 11602588
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva.
Rousseau K; Kirkham S; Johnson L; Fitzpatrick B; Howard M; Adams EJ; Rogers DF; Knight D; Clegg P; Thornton DJ
Biochem J; 2008 Aug; 413(3):545-52. PubMed ID: 18426393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
